Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $92 at Truist Securities

April 28, 2026 4:36 PM
Truist Securities analyst Richard Newitter lowered the price target on Zimmer Biomet (NYSE: ZBH) to $92.00 (from $98.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change